August 3, 2021

Volume XI, Number 215

Advertisement

August 03, 2021

Subscribe to Latest Legal News and Analysis

August 02, 2021

Subscribe to Latest Legal News and Analysis

Biotechnology, Life Sciences, Food and Drug Law News

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

Date Title Organization
13
May
Restaurant Revitalization Fund: Economic Relief for Restaurants Norris McLaughlin P.A.
13
May
Virginia Enacts Employment Protections For Medical Use of Cannabis Oil Hunton Andrews Kurth
13
May
International Coalition of Competition Enforcement Agencies Seek Public Comment to Explore “New or Refreshed” Theories of Competitive Harm Related to Pharmaceutical Mergers Mintz
13
May
Thailand Notified WTO of Four Draft Food-Contact Regulations Keller and Heckman LLP
12
May
Health Law Diagnosed — Hot Topics in FDA Regulation and Enforcement [PODCAST] Mintz
12
May
CFIUS Clearance: Just Eat Takeaway.com and Grubhub Squire Patton Boggs (US) LLP
12
May
Texas House Passes Plant-, Cell-, and Insect-Based Food Labeling Restrictions Keller and Heckman LLP
11
May
FDA Opens Industry Portal for FSVP Records Submission Keller and Heckman LLP
11
May
Massachusetts Public Health Council Approves Amendments to Clinic Licensure Regulations Mintz
11
May
The U.S. Government Says “Open Sesame”: How Science Informs the Regulatory Process Womble Bond Dickinson (US) LLP
11
May
Brexit and novel food procedures Keller and Heckman LLP
10
May
Waiver Of Intellectual Property Protections For COVID-19 Vaccine Unlikely To Have Meaningful Impact In Short Term Sheppard, Mullin, Richter & Hampton LLP
10
May
The American Families Plan & A Call for Drug Pricing Legislation Mintz
10
May
FDA Notice Concerning “Healthy” Symbol Keller and Heckman LLP
10
May
CNIL Issues Provisional Recommendations for Remote Quality Control of Clinical Trials During the Health Crisis McDermott Will & Emery
10
May
Alabama Legislature Approves Medical Marijuana: Roll Tide! (and a Joint?) Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
8
May
FDA Proposes Risk-Based and Remote Inspection Strategies in New Report Sheppard, Mullin, Richter & Hampton LLP
7
May
FDA Releases Forward-Looking Report on Inspections Keller and Heckman LLP
7
May
Court Issues a Rare, Severe Discovery Sanction: The Path that Led to Default Judgment Nelson Mullins
7
May
EC Review of Its Recommendation on the Definition of Nanomaterial Includes Targeted Stakeholder Consultation Bergeson & Campbell, P.C.

Pages